A comparison between two different definitions of contrast-associated acute kidney injury for long-term mortality in patients with diabetes undergoing coronary angiography: a prospective cohort study

作者:Lun, Zhubin; Lei, Li; Zhou, Dianhua; Ying, Ming; Liu, Liwei; Chen, Guanzhong; Liu, Jin; He, Yibo; Li, Huanqiang; Huang, Zhidong; Yang, Yongquan; Ye, Jianfeng*; Liu, Yong*
来源:BMC Cardiovascular Disorders, 2020, 20(1): 485.
DOI:10.1186/s12872-020-01778-6

摘要

Background The definitions of contrast-associated acute kidney injury (CA-AKI) are diverse and have different predictive effects for prognosis, which are adverse for clinical practice. Few articles have discussed the relationship between these definitions and long-term prognosis in patients with diabetes. Methods A total of 1154 diabetic patients who were undergoing coronary angiography (CAG) were included in this study. Two definitions of CA-AKI were used: CA-AKI(A) was defined as an increase >= 0.3 mg/dl or > 50% in serum creatinine (SCr) from baseline within 72 h after CAG, and CA-AKI(B) was defined as an increase >= 0.5 mg/dl or > 25% in SCr from baseline within 72 h after CAG. We used Cox regression to evaluate the association of these two CA-AKI definitions with long-term mortality and calculate the population attributable risks (PARs) of different definitions for long-term prognosis. Results During the median follow-up period of 7.4 (6.2-8.2) years, the overall long-term mortality was 18.84%, and the long-term mortality in patients with CA-AKI according to both CA-AKI(A) and CA-AKI(B) criteria were 36.73% and 28.86%, respectively. We found that CA-AKI(A) (HR: 2.349, 95% CI 1.570-3.517, p = 0.001) and CA-AKI(B) (HR: 1.608, 95% CI 1.106-2.339, p = 0.013) were associated with long-term mortality. The PARs were the highest for CA-AKI(A) (31.14%), followed by CA-AKI(B) (14.93%). Conclusions CA-AKI is a common complication in diabetic patients receiving CAG. The two CA-AKI definitions are significantly associated with a poor long-term prognosis, and CA-AKI(A), with the highest PAR, needs more clinical attention.

  • 单位
    广东医学院; y; 1; 广东省心血管病研究所; 南方医科大学; 广东省人民医院